FindTrial
Sign In

Improvement effect of Japanese apricot (Prunus mume Siebold et Zucc; Ume) on lower intestinal microflora.

Improvement effect of Japanese apricot (Prunus mume Siebold et Zucc; Ume) on lower intestinal microflora. - Improvement effect of Japanese apricot on intestinal microflora.

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024878
Enrollment
100
Registered
2016-11-17
Start date
2013-04-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy stomach, atrophic gastritis

Interventions

Japanese apricot (Prunus mume Siebold et Zucc
Ume) products placebo

Sponsors

School of Medicine, Wakayama Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy volunteer and those people with atrophic gastritis

Exclusion criteria

Exclusion criteria: The person of allergy to Japanese apricot, a person with a history of the gastrectomyand Hp erradication, the person who takes PPI and H2 receptor blocker, the person of allergy to peach, a person with the renal disfunction.

Design outcomes

Primary

MeasureTime frame
adverse event the Improvement effect of Japanese apricot on lower intestinal microflora , serum cytokine, serum triglyceride and serum cholesterol value—

Countries

Japan

Contacts

Public ContactTakao Maekita

School of Medicine, Wakayama Medical University Department of Gastroenterology

maekita@wakayama-med.ac.jp073-447-2300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026